Eurofins-Cerep SA (EPA:ALECR)
France · Delayed Price · Currency is EUR 16,100
0.00 (0.00%)
Jan 20, 2026, 11:30 AM CET
Eurofins-Cerep Market Cap
Eurofins-Cerep has a market cap or net worth of €77.68 million as of April 2, 2026. Its market cap has decreased by -25.24% in one year.
Market Cap
77.68M
Enterprise Value
64.09M
Revenue
38.86M
Ranking
n/a
PE Ratio
12.61
Stock Price
€16,100.00
Market Cap Chart
Since January 5, 2015, Eurofins-Cerep's market cap has decreased from 1.18B to 77.68M, a decrease of -93.41%. That is a compound annual growth rate of -21.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 77.68M | -13.48% |
| Dec 31, 2025 | 89.78M | -9.18% |
| Dec 31, 2024 | 98.86M | -21.60% |
| Dec 29, 2023 | 126.10M | 45.35% |
| Dec 23, 2021 | 86.76M | 32.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 99.89B |
| EssilorLuxottica Société anonyme | 91.57B |
| Sartorius Stedim Biotech | 16.17B |
| Ipsen | 13.17B |
| Crossject Société Anonyme | 109.17M |
| MaaT Pharma | 102.74M |
| Innate Pharma | 98.97M |
| Adocia | 91.70M |